Rifampicin-resistant strains of Mycobacterium leprae may have reduced virulence

R D McDermott-Lancaster1, G R Hilson

  • 1Department of Medical Microbiology, St. George's Hospital Medical School, London.

Insights

Rifampicin-resistant Mycobacterium leprae showed reduced infectivity in normal mice but could infect nude mice. This suggests decreased virulence, impacting the risk of human disease from resistant leprosy strains.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Leprosy, caused by Mycobacterium leprae, is a curable infectious disease.
  • Rifampicin (RMP) is a key drug in multidrug therapy for leprosy.
  • Emergence of drug-resistant M. leprae strains poses a significant public health challenge.

Purpose of the Study:

  • To investigate the infectivity and virulence of a rifampicin-resistant (RMP-resistant) Mycobacterium leprae strain in mouse models.
  • To compare the infectivity of RMP-resistant M. leprae with RMP-sensitive M. leprae in normal and immunocompromised mice.

Main Methods:

  • Infection studies using RMP-resistant and RMP-sensitive M. leprae strains in the foot pads (FP) of normal and nude (athymic) mice.
  • Varying inocula doses (10, 100, or 10^4 bacilli/FP) were used to assess infectivity.
  • Serial passage in mice was employed to maintain the RMP-resistant strain.

Main Results:

  • RMP-resistant M. leprae failed to infect normal mice at doses of 10 or 100 bacilli/FP.
  • Normal mice were infectable with RMP-sensitive M. leprae at 10 bacilli/FP.
  • Nude (athymic) mice were successfully infected with RMP-resistant M. leprae at an inoculum of 10 bacilli/FP.

Conclusions:

  • The RMP-resistant M. leprae strain exhibited reduced virulence in normal mice.
  • The findings suggest that RMP-resistant M. leprae may have a lower probability of causing disease in immunocompetent individuals.
  • Further research is needed to understand the full implications for human leprosy caused by drug-resistant strains.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbial Interactions: Parasitism01:22

Microbial Interactions: Parasitism

Parasitism is a form of microbial interaction in which parasitic microbes exploit a host organism for nutrients and shelter, often at the host's expense. Unlike mutualistic relationships, where both organisms benefit, parasitism benefits only the parasite and harms the host.Classification of ParasitesMicrobial parasites are broadly classified based on their location relative to the host.Ectoparasites remain on the host’s surface, such as the skin or outer tissues, drawing nutrients...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...